$ODYS ripping premarket! 🚀 Up 145% 🔹 Odyssey Therapeutics is a clinical-stage biotech focused on autoimmune and inflammatory diseases 🧬 🔹 Huge momentum afte

$ODYS ripping premarket! 🚀 Up 145% 🔹 Odyssey Therapeutics is a clinical-stage biotech focused on autoimmune and inflammatory diseases 🧬 🔹 Huge momentum after its upsized IPO, raising major capital to advance its pipeline 💰 🔹 Lead candidate OD-001 is being developed for ulcerative colitis, with…